We've found
9,144
archived clinical trials in
Ocular
We've found
9,144
archived clinical trials in
Ocular
Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT
Updated: 3/31/2016
Retrospective, Uncontrolled, Multicenter, Case History Study to Determine the Natural History of Visual Function in Subjects With Inherited Retinal Disease (IRD) Caused by Inherited Mutation of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT)
Status: Enrolling
Updated: 3/31/2016
Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT
Updated: 3/31/2016
Retrospective, Uncontrolled, Multicenter, Case History Study to Determine the Natural History of Visual Function in Subjects With Inherited Retinal Disease (IRD) Caused by Inherited Mutation of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT)
Status: Enrolling
Updated: 3/31/2016
Click here to add this to my saved trials
Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT
Updated: 3/31/2016
Retrospective, Uncontrolled, Multicenter, Case History Study to Determine the Natural History of Visual Function in Subjects With Inherited Retinal Disease (IRD) Caused by Inherited Mutation of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT)
Status: Enrolling
Updated: 3/31/2016
Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT
Updated: 3/31/2016
Retrospective, Uncontrolled, Multicenter, Case History Study to Determine the Natural History of Visual Function in Subjects With Inherited Retinal Disease (IRD) Caused by Inherited Mutation of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT)
Status: Enrolling
Updated: 3/31/2016
Click here to add this to my saved trials
Proof of Concept Study to Evaluate Safety and Efficacy of LME636 in the Treatment of Acute Anterior Uveitis
Updated: 4/4/2016
A Multicenter, Randomized, Double-Masked, Active-Controlled Study to Evaluate the Safety and Efficacy of LME636 in Patients With Acute Anterior Uveitis
Status: Enrolling
Updated: 4/4/2016
Proof of Concept Study to Evaluate Safety and Efficacy of LME636 in the Treatment of Acute Anterior Uveitis
Updated: 4/4/2016
A Multicenter, Randomized, Double-Masked, Active-Controlled Study to Evaluate the Safety and Efficacy of LME636 in Patients With Acute Anterior Uveitis
Status: Enrolling
Updated: 4/4/2016
Click here to add this to my saved trials
Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)
Updated: 4/5/2016
Zeaxanthin as an Adjuvant to Combination Therapy for Treatment of Choroidal Neovascularization (CNV) in Exudative Age Related Macular Degeneration (ARMD)
Status: Enrolling
Updated: 4/5/2016
Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)
Updated: 4/5/2016
Zeaxanthin as an Adjuvant to Combination Therapy for Treatment of Choroidal Neovascularization (CNV) in Exudative Age Related Macular Degeneration (ARMD)
Status: Enrolling
Updated: 4/5/2016
Click here to add this to my saved trials
Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment
Updated: 4/5/2016
Triple Combination Therapy of Choroidal Neovascularization in Exudative Age-related Macular Degeneration - a Cost Effect and Efficient Therapeutic Treatment
Status: Enrolling
Updated: 4/5/2016
Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment
Updated: 4/5/2016
Triple Combination Therapy of Choroidal Neovascularization in Exudative Age-related Macular Degeneration - a Cost Effect and Efficient Therapeutic Treatment
Status: Enrolling
Updated: 4/5/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Updated: 4/7/2016
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials